Pulse-dose-rate interstitial brachytherapy in anal squamous cell carcinoma: clinical outcomes and patients' health quality perception

CONCLUSIONS: In this cohort of 42 patients with mainly I and II tumor stages, PDR-BT boost allowed for local control in 88.7% of patients, with only one grade 3 anorectal toxicity.PMID:34122565 | PMC:PMC8170522 | DOI:10.5114/jcb.2021.106247

Source: Journal of Contemporary Brachytherapy - June 14, 2021 Category: Cancer & Oncology Authors: R émi Bourdais Samir Achkar Sophie Espenel Sophie Bockel Laetitia Chauffert-Yvart Florence Ravet de Mellis Minh-Hanh Ta Wassila Boukhelif J érôme Durand-Labrunie Pascal Burtin Christine Haie-Meder Eric Deutsch Cyrus Chargari Source Type: research